Vanda Pharmaceuticals (VM4.F) Q3 2025 Earnings

31JulConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.51
-0.36
-0.22
-0.08

Details

Expected EPS
-0.31229762520000004
Actual EPS
-0.402776
Surprise EPS
-0.09
Surprise Percent
+28.97%

Description

Vanda Pharmaceuticals (VM4.F) has reported earnings of -0.402776 per share for Q3 2025.

0 Comments

Share your thoughts